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enzymatic peptide and protein labeling†
T. M. Simon Tang, Davide Cardella, Alexander J. Lander, Xuefei Li,
Jorge S. Escudero, Yu-Hsuan Tsai and Louis Y. P. Luk *
Asparaginyl endopeptidases (AEPs) are ideal for peptide and protein labeling. However, because of the
reaction reversibility, a large excess of labels or backbone modified substrates are needed. In turn, simple
and cheap reagents can be used to label N-terminal cysteine, but its availability inherently limits the
potential applications. Aiming to address these issues, we have created a chemo-enzymatic labeling
system that exploits the substrate promiscuity of AEP with the facile chemical reaction between N-
terminal cysteine and 2-formyl phenylboronic acid (FPBA). In this approach, AEP is used to ligate
polypeptides with a Asn–Cys–Leu recognition sequence with counterparts possessing an N-terminal
Gly–Leu. Instead of being a labeling reagent, the commercially available FPBA serves as a scavenger
converting the byproduct Cys–Leu into an inert thiazolidine derivative. This consequently drives the AEP
labeling reaction forward to product formation with a lower ratio of label to protein substrate. By
carefully screening the reaction conditions for optimal compatibility and minimal hydrolysis, conversion
to the ligated product in the model reaction resulted in excellent yields. The versatility of this AEP-
ligation/FPBA-coupling system was further demonstrated by site-specifically labeling the N- or C-termini
of various proteins.Introduction
There has been a vast expansion in the toolkit of protein bio-
conjugation,1–3 drawing on expertise from both biological4–6 and
organic7–12 chemistry. Protein-based approaches offer the ability
to function efficiently under mild reaction conditions.5,6
Transferase,13–15 oxidoreductase,16–18 ligase,19,20 trans-
peptidase2,4,21–27 and (split-)intein28–30 have been applied for
protein bioconjugation. Nevertheless, adapting these enzymes
or proteins for synthetic applications, which deviate from their
natural function, oen results in technical issues. Whereas
stability and solubility of intein-fused constructs are extremely
case-dependent,28–30 reversible enzymatic reactions need to be
suppressed by a large excess of label24,31 or unstable substrate
that has inherent limitation to where bioconjugation takes
place.32–34 In contrast, chemical approaches with commercially
available reagents are simple to perform and have become
standard practice.4,8–10 However, efficiency and selectivity of
these reactions relies on the availability of specic residues,
which varies greatly among proteins.2,35 These descriptions
apply to the bioconjugation reaction mediated by the enzyme
asparaginyl endopeptidase (AEP) and the chemical labeling ofn Building, Park Place, Cardiff, CF10 3AT,
tion (ESI) available. See DOI:
of Chemistry 2020N-terminal cysteine by 2-formyl phenylboronic acid (FPBA).
Here, we combine their strengths together, such that site-
specic protein labeling can be achieved at the terminus of
choice (N or C).
Many asparaginyl endopeptidases (AEPs) from plants
possess transpeptidase function and present as ideal bio-
catalysts for protein labeling (i.e., intermolecular liga-
tion).24,26,27,36–38 AEP hydrolyzes the C-terminal amide bond of an
internal asparagine or aspartate residue (P1) and subsequently
mediate ligation to the N-terminus of an incoming nucleophile
peptide (Fig. 1).26,36,39–41 Some important examples of AEP
include butelase 1 and OaAEP1, and their excellent kinetic
properties and relatively short recognition sequence (3 amino
acids, P1–P10–P20) are the key advantages. Protein substrates
including GFP, ubiquitin, ompA, DARPin, maltose binding
proteins and nanobodies have previously been modied by
AEPs, whereas unnatural amino acids, click handles, modied
residues, polyethylene glycol, uorophores, biotin and drug
molecules have been used as labels.24,26,31,32,42–45 However,
similar to other transpeptidases, bioconjugation by AEP
requires a relatively large excess of labeling agents, with respect
to the protein.31 This becomes a major hurdle for expensive or
non-commercially available labels (e.g., isotopic, radioactive
and uorescent labels).46–49
One valuable feature of AEPs is their relatively relaxed
substrate specicity, which has been used to improve the
enzyme-catalyzed bioconjugation reaction.26,36,38,39,41,48,49Chem. Sci.
Fig. 1 AEP catalyzes the hydrolysis of the amide bond between amino acids P1 (Asx) and P10 followed by the ligation of the a-amine of P100.
Various approaches have been reported to drive the reaction equilibrium towards product formation, including the use of (A) thiodepsipeptides32
and (B) self-assembling protein domains.48,49 (C) Here, a chemo-enzymatic approach that incorporates N-terminal cysteine trapping by for-
mylphenyl boronic acid (FPBA) was reported. (Inset) Crystal structure overlay of the active sites of OaAEP1 (orange, 5H0I) and butelase 1 (blue,
6DHI), with the catalytic diad ofOaAEP1 and butelase 1 highlighted in black and grey, respectively. Residues are numbered according to OaAEP1.
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View Article OnlineAsparaginyl thiodepsipeptides have been used to develop irre-
versible butelase 1-mediated labeling (Fig. 1A). However, these
alternative substrates have extremely short half-lives (k1/2z 45–
75 min at pH 6.5) and effective labeling requires four to ve
equivalent excess of label, added in small portions.32,50 More-
over, labeling with the use thiodepsipeptide is limited to the N-
terminus.32 Other solutions include the use of split proteins
which have inherent affinity towards each other (Fig. 1B),48,49
but it requires the insertion of a large split-protein domain.
Rehm et al. has illustrated that the reactivity difference between
two recognition sequences at P2' (Asn–Gly–Leu versus Asn–Gly–
Val) can be exploited to avoid hydrolysis catalyzed by OaAEP1,
a homologue that carries signicant sequence identity to
butelase 1 (66%) (Fig. 1 inset).24 However, a large excess of
labeling agents (20–120 equivalents, relative to the protein
substrate) for intermolecular ligation was used. It has also been
demonstrated Asn–Cys–Leu (P1–P10–P20) can be recognized for
ligation by OaAEP1;48,49 such a reaction will generate byproduct
that carries a N-terminal cysteine (Cys–Leu) whose reactivity can
be exploited to develop an irreversible AEP-reaction and has yet
to be explored.
The 1,2-aminothiol functionality of N-terminal cysteine
contains two nucleophilic centers, and thus it can react with
aldehydes to form thiazolidinones.51–54 2-Formyl phenylboronic
acid (FPBA) is one such electrophile that reacts with N-terminal
cysteine with exquisite selectivity and efficiency.53,54 With
biomolecular rate constant measured up to 105 M1 s1, FPBA
and its derivatives have been used for polypeptide labeling.53,54
Nevertheless, preparing proteins with a N-terminal cysteine is
case-dependent and can be a challenging task.30,55–59 While
successful examples have been reported, the N-terminal
cysteine can readily react during gene expression (e.g. pyru-
vate) limiting the potential FPBA labeling reaction.30,55–59Chem. Sci.Instead, this cheap and commercially available reagent can be
used as a scavenger for AEP catalysis. We propose that the non-
natural secondary amine motif formed between FPBA and N-
terminal cysteine is unlikely to be a reactive substrate for AEP
catalysis, and thus the byproduct of the enzymatic reaction Cys–
Leu can be potentially trapped by the addition of FPBA. To this
end, an irreversible AEP-labeling system can be achieved, such
that bioconjugation can take place at the terminus of choice (N
or C) with minimal modication using a lower ratio of label to
protein (Fig. 1C).
Here, we develop a chemo-enzymatic protein labeling
strategy, whereby the intermolecular ligation by AEP is coupled
to a FPBA reaction that quenches the ligation byproduct. The
P1–P10–P20 recognition sequence used for AEP labeling is Asn–
Cys–Leu, and FPBA is added as a scavenger that reacts with the
1,2-aminothiol motif of Cys–Leu (Fig. 1C).53,54 Consequently, the
AEP-mediated peptide ligation can be driven forward, whilst
lowering the amount of labeling reagents used. By carefully
tuning the amount of FPBA, pH, temperature and reaction time,
the newly developed labeling system has minimal hydrolysis for
the label, protein substrate and product. In our model peptide
ligation reactions, this chemo-enzymatic approach proceeds in
excellent yields (up to 95%). We have also proved our concept by
labeling the N- or C-terminus of proteins of different sequences.Results and discussion
Preparation of OaAEP1–C247A
The AEP variant derived from Oldenlandia affinis OaAEP1–
C247A was chosen due to the availability of its recombinant
procedure, and this variant was also reported to have activity
superior to that of the wild type and comparable to that of
butelase 1 (under their respective optimized reactionThis journal is © The Royal Society of Chemistry 2020
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View Article Onlineconditions) (Fig. 1 inset).24,39 However, in the literature, a pro-
domain was included during gene expression, and thus enzyme
activation under acidic condition was required.24,26,37 Although,
in agreement with the literature,26,37 the activity of the activated
enzyme can be mildly improved (15%, ESI Fig. S1†) aer
subjecting the activated OaAEP1–C247A to cation exchange
chromatography, a lengthy preparation protocol is not desir-
able. With a view on practicality, we have simplied the enzyme
preparation protocol by expressing the gene of the active
enzyme fused with a ubiquitin and a hexahistidine tag. The
enzyme yield is comparable to existing approaches (2 mg vs.
1.8 mg, see ESI† for more information),26 but the steps involved
are reduced. Furthermore, this simplied enzyme construct
showed comparable kinetic behaviors to the acid activated
OaAEP1–C247A (for comparisons between the kcat and KM
values, see Table S1†)24,39 and was shown to mediate protein
bioconjugation via the chemo-enzymatic approach described
below.Substrate specicity of OaAEP1–C247A
The hydrolysis and nucleophile peptide proles for peptide
cyclization by OaAEP1 has been previously reported.24,26,37,39 To
complement these reports, here we present the hydrolysis
prole for intramolecular OaAEP1–C247A (Fig. 2). The model
ligation reaction between CFRANXL (where X at P10 position is
any of the 20 amino acids, 50 mM) and GLGGIR (250 mM, 5
equivalents) was performed at pH 5.0 with 0.1 mM of enzyme
(1 : 500 enzyme to substrate ratio, Fig. 2A). Specicity at the P10
position is rather relaxed; OaAEP1–C247A was able to hydrolyze
the peptide bond between asparagine and all 20 amino acidsFig. 2 Hydrolysis profile for peptide ligation catalyzed by OaAEP1–
C247A. (A) The ligation of CFRANXL to GLGGIR, with the investigated
alternative recognition sequence (Asn–Cys–Leu) colored in red, and
(B) the profile using CFRANGX, where X is any of the 20 amino acids.
This journal is © The Royal Society of Chemistry 2020except proline (Fig. 2A). Similar to the previous work that
characterized the wild-type OaAEP1,48,49 Asn–Cys–Leu can also
be recognized by the C247A variant, thus allowing us to develop
the proposed coupling between AEP catalysis and cysteine/FPBA
reaction (Fig. 1C). In contrast, specicity at the P20 position is
more restricted. When CFRANGX was used, the enzyme prefers
large hydrophobic residues such as Phe, Ile, Leu, Met and Trp
(Fig. 2B). Furthermore, echoing the report by Rehm et al.,24 our
hydrolysis prole also illustrates that a Val residue at the P20
position results in poor hydrolytic activity. The P20 preference of
OaAEP1–C247A also resembles the P200 acceptor prole of
butelase 1, an AEP with signicant sequence identity (66%)
(Fig. 1; inset).26,36 Based on previous studies of OaAEP1,24,26,37,39
G and L at P100 and P200 represent one of the most effective
combination for the nucleophile peptide. Nevertheless, other
combinations of residues can also be used, as long as they do
not interfere with the reactivity of FPBA (e.g., avoid N-terminal
cysteine) and are suitable for the specic AEP variant used.39
Kinetic characterizations of OaAEP1–C247A and FPBA
conjugation
The aim of this work is to quench the reactivity of the P10–P20
byproduct (Cys–Leu) generated from the AEP labeling reaction
by including the electrophile FPBA (Fig. 1C). Consequently, the
compatibility between AEP catalysis and cysteine/FPBA reaction
was investigated. A model thiazolidine formation reaction
between FPBA and a N-terminal cysteine peptide CFRANGL was
monitored by a reported UV spectroscopic assay.53,54 Gratify-
ingly, the bioconjugation reaction took place at all examined
pH's with rate constants ranging from 0.7  103 M1 s1 at pH
5.0 to 6.0  103 M1 s1 at pH 7.0 (Fig. S2†). For OaAEP1–C247A
catalysis, the pH rate prole indicates that the catalytic turnover
constant (kcat) can be as high as 7.5 s
1 at pH 5.0 and decreases
to 1 s1 at pH 7.5 at 20 C. Since the Michaelis constant (KM)
remains largely unchanged, the catalytic efficiency (kcat/KM) was
found to be within a three-fold difference from pH 5.0 to 7.5 (2.8
to 0.9  104 M1 s1) (Fig. S3†). In the other words, the two
reactions are kinetically compatible at the examined pH range
(5.0–7.0). Even at a low concentration (e.g., mM to mM range),
the rate of thiazolidine formation is compatible to the catalytic
turnover for OaAEP1–C247A.
Intermolecular peptide ligation mediated by OaAEP1–C247A
One consideration is that AEPs are able to catalyze hydrolysis of
internal asparagine (and aspartate) residues using water as the
nucleophile.26,37,38,43 Consequently, the label, substrate or
product could be hydrolyzed to yield unwanted side-products.
Using the intermolecular ligation reaction between the
peptides LFRANCLK and GLGGIR (Table 1; eqn (1)) as a model,
we have isolated several key variables that inuence the extent
of hydrolysis by OaAEP1–C247A.
The pH of the reaction was kept at $5.0 to minimize the
undesired hydrolytic reaction (Table 1; entry 1–6. Table S2;†
entry 42–43, 56–57, 62–63, 72–73 for reactions tested at pH 4.5–
5.7); similar observations were made in the studies of AEP from
other plant species.36,40 Hydrolysis was found to be furtherChem. Sci.
Table 1 Model reaction catalyzed by OaAEP1–C247A in the absence
and presence of 2-formyl phenylboronic acid (FPBA)a
Entry pH X Z GZGGIRb (equiv.) Time (h)
Conversion (%)
()
FPBA (+) FPBA
1 5.0c Cys Leu 1.2 3 53e 89e
2 5.2c 3 54f 95f
3 5.5d 3 49f 85f
4 4 48f 90f
5 5.7d 3 51g 78g
6 4 50g 94g
7 5.7d Ala 3 67g 61g
8 4 70g 67g
9 5.7d Cys Val 1.0 4 24f 45f
10 1.5 33f 55f
11 2.0 32f 66f
12 5.0 65g >95g
13 10.0 >95g >95g
14 20.0 >95g >95g
a All reactions were carried out in triplicate with OaAEP1–C247A (0.3
mM), LFRANXLK (300 mM) and GZGGIR (300–6000 mM) at 20 C.
OaAEP1–C247A prepared from acid activation of the zymogen and
from the simplied construct were used. b Equivalents of labeling
peptide used relative to the peptide substrate, LFRANXLK. c 50 mM
NaOAc buffer with 50 mM NaCl, 1 mM EDTA, 0.5 mM TCEP. d 50 mM
MES buffer with 50 mM NaCl, 1 mM EDTA, 0.5 mM TCEP. e 10–15%.
f 5–10%. g <5% of the undesired hydrolysis product observed.
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View Article Onlineminimized when the temperature was kept at #20 C (Table
S2;† entry 46–53 and 92–96 for reactions tested at 20 and 37 C).
Also, reaction time needed to be carefully screened in order to
strike a balance between hydrolysis and product formation
(Table S2;† entry 58–59). While AEP can hydrolyze peptide upon
prolonged incubation,36,40 FPBA was also found to slow the
process of peptide ligation. This is likely because of reversible
interactions with either the enzyme or the nucleophilic peptide
(e.g., forming iminium ion; Table 1; entry 3–6 and entry 80–85 in
Table S2†). Based on the +100 polypeptide reactions tested here,
the reaction time was kept in between 2 and 18 h, with a mode
average of 4 h.24 Lastly, a relatively small excess of theTable 2 C-terminus labeling of eGFP with biotinylated peptide using
OaAEP1–C247A in the presence of 2-formyl phenylboronic acid
(FPBA)
Entry GLGGZa (equiv.) Yield (%) Hydrolysis (%)
1 1.0 63 4
2 1.2 66 1
3 1.5 75 2
4 2.0 86 0
a Equivalents of labeling peptide used relative to the protein substrate
eGFP. It should be noted that an Asp-to-Ala mutation was needed to
avoid undesired side-product (Table S3).
Chem. Sci.nucleophilic peptide (1.2–2 equivalents) was used to further
diminish hydrolysis (Tables 1 and 2 and entry 30–32 in Table
S1†).
Under the optimized conditions, 94% of the ligated product
LFRANGLGGIR was obtained in 4 h at pH 5.7 using 1.2 equiv-
alent of the nucleophilic peptide, when FPBA was included in
the system (Table 1; entry 6). In contrast, when FPBA was
excluded, product conversion was stalled at 50% (Table 1;
entry 1–6). For the cysteine-free peptide LFRANALK, no signi-
cant difference in ligation yield was observed by adding FPBA
(Table 1; entry 7–8). Also, the enzymatic activity difference
between the P1–P10–P20 recognition sequences Asn–Cys–Leu
and Asn–Gly–Leu was only about 10% (Fig. 2A). Together, these
observations indicate that the increase of reaction yield (>40%,
Table 1) is caused by the coupling between the FPBA reaction
and AEP ligation.
Recently, it has been demonstrated that hydrolysis can be
avoided by using polypeptides that carry Gly–Val as the P100–P200
nucleophile.24 To examine if this concept can be applied to the
chemo-enzymatic strategy described here, an alternative
peptide GVGGIR was tested in the model ligation reaction
(Table 1; entries 9–14).24 Independent of FPBA addition, excel-
lent conversion (>95%) was observed using 10–20 equivalents of
peptides. However, when only 1–5 equivalents of GVGGIR were
used, conversion was found to be 1.5 to 2-fold higher in the
reactions that included FPBA. Nevertheless, product conversion
was notably lower when compared to those where GLGGIR were
used, thus suggesting that Gly–Val nucleophile is less suitable
for the chemo-enzymatic approach. Consequently, nucleophilic
peptides with Gly–Leu at the N-terminus were used for protein
bioconjugation.OaAEP1–C247A mediated protein bioconjugation
The newly developed AEP-ligation/FPBA-coupling approach
was employed for site-specic C-terminal labeling. A linker
containing Asn–Cys–Leu was added to the C-terminus of
enhanced green uorescent protein (eGFP), and ligation reac-
tions with the biotinylated peptide GLGGZ (where Z is bio-
tinylated lysine) were performed. Estimated by LC-MS
analysis,10,24,60 the yield of the C-terminally modied protein
increased up to 1.5-fold when FPBA is included (Table S3†),
and up to 92% of the C-terminally modied protein could be
achieved using two equivalents of the biotin label (Table 2 and
Fig. 3). Similar ndings were observed in the labeling of other
monomeric and multimeric proteins. 85% of b-lactamase was
modied at the C-terminus under the same reaction condition
(Fig. 3). As demonstrated here and in previous works,27,37 AEP
functions from pH 5.0–7.5, but some proteins may become
unstable even under mildly acidic environments. Hence, the
presented labeling system was also tested with the engineered
lumazine synthase AaLS-13, a macromolecular complex
composed of 360 protein subunits which is prone to precipi-
tation at pH below 7.0.63–65 Up to 75% of the AaLS-13 subunits
were found to be labeled under neutral pH condition (Fig. 3).
While it is of little doubt that full conversion can be achieved by
using a slightly higher equivalent of labeling peptide (Table 2),This journal is © The Royal Society of Chemistry 2020
Fig. 3 Protein modification. Proteins (100 mM) modified with a short linker and the recognition sequence (Asn–Cys–Leu) for OaAEP1 were
incubated with biotin labeled peptide (200 mM), OaAEP1-C247A (0.25 mM) and FPBA (200 mM). The reactions were quenched with 1 M HCl then
analyzed by UPLC-MS. SM refers to starting material and P to product. (*) Denotes peaks correlating to a-N-gluconoylation of recombinant
protein startingmaterial and products (+178 Da).61,62 (+) Denotes conversion averaged from repeated experiments, associated errors are reported
in Fig. S5, S6 and S8.† Asp-to-Ala mutation was introduced to eGFP in order to avoid undesired hydrolytic reaction (Table S3†). The corre-
sponding chromatograms and full mass spectra of the UPLC-MS analysis are reported in Fig. S5–S9.† Other than the species reported above,
there is no evidence of hydrolyzed peptides or formation of any other byproducts. Quenching by the addition of 1 M HCl was used solely for the
purpose of obtaining a precise reaction time during optimization.
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View Article Onlinereactions performed here were capped at two equivalents to
demonstrate the effectiveness of this approach at a relatively
low label-to-protein ratio. In a similar fashion, ubiquitin
bearing a C-terminal Asn–Cys–Leu sequence could be labeled
with the biotinylated peptide GLGGZ (Fig. 3). These ndings
illustrate that the chemo-enzymatic approach is suitable for
a range of proteins with different sequence and biophysical
properties, whilst lowering the ratio of label to protein
substrate needed, and is complementary to the existing site-
specic C-terminal modication technologies.12,24,32,42–44,60,66,67
Since only natural amino acids are needed for recognition,
the chemo-enzymatic method was also applied for site-specic
N-terminus labeling. Ubiquitin containing an extra Gly–Leu
sequence at the N-terminus was recombinantly prepared as the
substrate, and biotin-labeled peptide bearing the recognition
sequence Asn–Cys–Leu at the C-terminus (i.e., biotin-ATRNCL)
was synthesized for labeling (see ESI†). 79% of ubiquitin was
labeled at the N-terminus using two equivalents of the bio-
tinylated label when FPBA was included (Fig. 3). This nding is
complementary to the previous work in which thiodepsipeptide
was used,32 but issue surrounding the stability of label was not
observed here. It should be noted that all the proteins used here
contained other internal asparagine and aspartate residues.
However, they are neither hydrolyzed nor modied with only
one exception. An Asp235Ala mutation at the solvent-exposed
internal site of eGFP (11 residues from the C-terminus) was
needed (Fig. S5 and Table S4†).68 In the other words, accessi-
bility plays a critical role in AEP-based modication, dictating
both the reaction yield and side reactions.This journal is © The Royal Society of Chemistry 2020Conclusions
The presented work combines the advantages of chemical and
enzymatic labeling, creating a bioconjugation system with
features that could not be achieved by either method alone.
Transpeptidases are appealing tools for bio-
conjugation,5,6,13,14,16,21,26,39,42 but their reactions are reversible,
and thus a large ratio of labeling agents to protein substrate is
needed to achieve high conversion.21,23,32,53,54,60,69 While the use
of backbone-modied labels such as (thio)depsipeptides has
improved yields of reactions catalyzed by sortase,33,34 sub-
tiligase,70,71 trypsiligase22,25 and AEPs,32 stability of these alter-
native labels varies signicantly and can be difficult to
prepare.50 Furthermore, the backbone-modied approach is
largely limited to N-terminal labeling.32,33,70 On the other hand,
FPBA is a commercially available reagent that offers a fast,
selective and simple method for modication,4,53,54 but prepa-
ration of proteins with a free N-terminal cysteine is not
universally trivial, as it is prone to side reaction (oxidation and
thiazolidinone formation).30,55–59 However, when the AEP catal-
ysis and FPBA bioconjugation are combined together, a system
that enables both N- and C-terminal ligation with the use of
stable labeling agents is developed.32
Provided that the AEP-ligation/FPBA-coupling method
lowers the ratio of label to protein substrate, it is particularly
applicable when expensive or non-commercially available labels
are used.46–49While some of the proteins labeled here, including
eGFP, beta-lactamase and AaLS13, contain cysteine residues (in
oxidized or reduced form), it should be noted that extension ofChem. Sci.
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View Article Onlinethis approach might require preliminary investigations, as
addition of cysteine residue could potentially destabilize some
proteins,72,73 particularly those that contains signicant number
of disulde bonds (e.g., anti- and nano-bodies).72,73 Since the
activity of OaAEP1 is limited to neutral or acidic conditions,37
studies towards the use of FPBA to enhance other enzymatic
labeling strategies may be worthwhile. The development in this
technology complements the use of existing transpeptidases
such as sortase, as the differences in substrate specicity may
be fully exploited in combination to develop orthogonal ligation
strategies.23,24,44 In summary, the pairing of enzymatic trans-
peptidation with well-established chemical reactions offers
a versatile and efficient approach to the preparation of tailored
protein constructs.
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